David J. Grainger

Insider Reports History

Entity
Individual
Location
C/O Centessa Pharmaceuticals Plc, 3 Rd Fl., 1 Ashley Rd, Altrincham, Cheshire, United Kingdom
Signature
/s/ Gregory Weinhoff, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David J. Grainger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Centessa Pharmaceuticals plc Chief Innovation Officer Ordinary Shares 963K $7.66M $7.96 Dec 31, 2023 Direct
Centessa Pharmaceuticals plc Chief Innovation Officer Ordinary Shares 27.5K $219K $7.96 Dec 31, 2023 Indirect

Insider Reports Filed by David J. Grainger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNTA Centessa Pharmaceuticals plc Dec 31, 2023 1 -$37.4K 4 Jan 2, 2024 Chief Innovation Officer
CNTA Centessa Pharmaceuticals plc Sep 30, 2023 1 -$30.4K 4 Oct 3, 2023 Chief Innovation Officer
CNTA Centessa Pharmaceuticals plc Jun 30, 2023 1 -$25.3K 4 Jul 3, 2023 Chief Innovation Officer
CNTA Centessa Pharmaceuticals plc Mar 31, 2023 1 -$18.8K 4 Apr 4, 2023 Chief Innovation Officer
CNTA Centessa Pharmaceuticals plc Feb 1, 2023 2 $0 4 Feb 3, 2023 Chief Innovation Officer
CNTA Centessa Pharmaceuticals plc Dec 31, 2022 1 -$7.74K 4 Jan 4, 2023 Chief Innovation Officer
CNTA Centessa Pharmaceuticals plc Sep 30, 2022 1 -$30.4K 4 Jan 13, 2023 Chief Innovation Officer
CNTA Centessa Pharmaceuticals plc Sep 30, 2022 0 $0 4/A Nov 23, 2022 Chief Innovation Officer
CNTA Centessa Pharmaceuticals plc Jul 1, 2022 1 $0 4 Jul 6, 2022 Chief Innovation Officer
CNTA Centessa Pharmaceuticals plc Feb 1, 2022 1 $0 4 Feb 3, 2022 Chief Innovation Officer
CNTA Centessa Pharmaceuticals plc Jan 28, 2022 1 $249K 4 Feb 1, 2022 Chief Innovation Officer
CNTA Centessa Pharmaceuticals plc Nov 1, 2021 1 $0 4 Nov 2, 2021 Chief Innovation Officer
CNTA Centessa Pharmaceuticals plc Oct 1, 2021 0 $0 3 Oct 8, 2021 Chief Innovation Officer